Erratum to 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway [Mol. Nutr. Food Res., 57 (2013) 471-482] DOI 10.1002/mnfr.201200529;3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway

Molecular Nutrition and Food Research

Volumn 57, Issue 3, 2013, Pages 471-482

  Pil Hwang, Yong ^a,b   Gyun Kim, Hyung ^a   Choi, Jae Ho ^a   Truong Do, Minh ^a   Tran, Thu Phuong ^a   Chun, Hyo Kon ^c   Chung, Young Chul ^b   Jeong, Tae Cheon ^d   Jeong, Hye Gwang ^a  

^a Chungnam National University   (South Korea)

^b International University of Korea   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Yeungnam University   (South Korea)

Author keywords

3 Caffeoyl, 4 dihydrocaffeoylquinic acid; AMPK; High glucose; Lipogenesis; LKB1

Indexed keywords

SALICORNIA HERBACEA;

EID: 84875051812     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201370044     Document Type: Erratum

References (46)

1. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S. et al., Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50, 1884-1850.
2. Kopelman, P. G., Obesity as a medical problem. Nature 2000, 404, 635-643.
3. Lois, K., Young, J., Kumar, S., Obesity; epiphenomaenon or cause of metabolic syndrome? Int. J. Clin. Pract. 2008, 62, 932-938.
4. Tamura, S., Shimomura, I., Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115, 1139-1142.
5. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L. et al., The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 2004, 101, 3329-3335.
6. Woods, A., Dickerson, K., Heath, R., Hong, S. P. et al., Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2, 21-33.
7. Long, Y. C., Zierath, J. R., AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 2006, 116, 1776-1783.
8. Jorgensen, S. B., Rose, A. J., How is AMPK activity regulated in skeletal muscles during exercise? Front Biosci. 2008, 13, 5589-5604.
9. Hardie, D. G., The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 2004, 117, 5479-5487.
10. Hardie, D. G., Minireview : the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003, 144, 5179-5183.
11. Saha, A. K., Avilucea, P. R., Ye, J. M., Assifi, M. M. et al., Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem. Biophys. Res. Commun. 2004, 314, 580-585.
12. Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M. et al., Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. USA 2008, 105, 9793-9798.
13. Horton, J. D., Goldstein, J. L., Brown, M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109, 1125-1131.
14. Rawson, R. B., Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs). Biochem. Soc. Symp. 2003, 70, 221-231.
15. Foretz, M., Ancellin, N., Andreelli, F., Saintillan, Y. et al., Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 2005, 54, 1331-1339.
16. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H. et al., The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310, 1642-1646.
17. Calkin, A. C., Tontonoz, P., Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 2012, 13, 213-224.
18. Han, S. K., Kim, S. M., Pyo, B. S., Antioxidative effect of glasswort (Salicornia herbacea L.) on the lipid oxidation of pork. Kor. J. Food Sci. Anim. Resour. 2003, 23, 46-49.
19. Chinnusamy, V., Zhu, J., Zhu, J. K., Salt stress signaling and mechanisms of plant salt tolerance. Genet. Eng. 2006, 27, 141-147.
20. Bang, M. A., Kim, H. A., Cho, Y. J., Hypoglycemic and antioxidant effect of dietary hamcho powder in streptozotocin-induced diabetic rats. J. Kor. Soc. Food Sci. Nut. 2002, 31, 840-846.
21. Chung, Y. C., Chun, H. K., Yang, J. Y., Kim, J. Y. et al., Tungtungmadic acid, a novel antioxidant, from Salicornia herbacea. Arch. Pharm. Res. 2005, 28, 1122-1126.
22. Im, S. A., Kim, K., Lee, C. K., Immunomodulatory activity of polysaccharides isolated from Salicornia herbacea. Int. Immunopharmacol. 2006, 6, 1451-1458.
23. Ryu, D. S., Kim, S. H., Lee, D. S., Anti-proliferative effect of polysaccharides from Salicornia herbacea on induction of G2/M arrest and apoptosis in human colon cancer cells. J. Microbiol. Biotechnol. 2009, 19, 1482-1489.
24. Hwang, Y. P., Yun, H. J., Chun, H. K., Chung, Y. C. et al., Protective mechanisms of 3-caffeoyl, 4-dihydrocaffeoyl quinic acid from Salicornia herbacea against tert-butyl hydroperoxide-induced oxidative damage. Chem. Biol. Interact. 2009, 181, 366-376.
25. Cho, A. S., Jeon, S.M., Kim, M. J, Yeo, J. et al., Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937-943.
26. Han, E. H., Kim, J. Y., Kim, H. G., Chun, H. K. et al., Inhibitory effect of 3-caffeoyl-4-dicaffeoylquinic acid from Salicornia herbacea against phorbol ester-induced cyclooxygenase-2 expression in macrophages. Chem. Biol. Interact. 2010, 183, 397-404.
27. Park, S. H., Ko, S. K., Choi, J. G., Chung, S. H., Salicornia herbacea prevents high fat diet-induced hyperglycemia and hyperlipidemia in ICR mice. Arch. Pharm. Res. 2006, 29, 256-264.
28. Hwang, J. Y., Lee, S. K., Jo, J. R., Kim, M. E. et al., Hypolipidemic effect of Salicornia herbacea in animal model of type 2 diabetes mellitus. Nutr. Res. Pract. 2007, 1, 371-375.
29. Zang, M. W., Zuccollo, A., Hou, X. Y., Nagata, D. et al., AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 2004, 279, 47898-47905.
30. Wang, Y. X., Lee, C. H., Tiep, S., Yu, R. T. et al., Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003, 113, 159-170.
31. Li, Y., Xu, S., Mihaylova, M. M., Zheng, B. et al., AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13, 376-388.
32. Lage, R., Diéguez, C., Vidal-Puig, A., López, M., AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med. 2008, 14, 539-549.
33. Moridani, M. Y, Scobie, H., Jamshidzadeh, A., Salehi, P. et al., Caffeic acid, chlorogenic acid, and dihydrocaffeic acid metabolism: glutathione conjugate formation. Drug Metab. Dispos. 2001, 29, 1432-1439.
34. Yoshimoto, M., Yahara, S., Okuno, S., Islam, M. S. et al., Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci. Biotech. Biochem. 2002, 66, 2336-2341.
35. Chiang, L., Ng, L. T., Chiang, W., Lin, C., Immuno-modulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003, 69, 600-604.
36. Prip-Buus, C., Perdereau, D., Foufelle, F., Maury, J. et al., Induction of fatty-acid-synthase gene expression by glucose in primary culture of rat hepatocytes. Dependency upon glucokinase activity. Eur. J. Biochem. 1995, 230, 309-315.
37. Yoshikawa, T., Shimano, H., Amemiya-Kudo, M., Yahagi, N. et al., Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 2001, 21, 2991-3000.
38. Cozzone, D., Debard, C., Dif, N., Ricard, N. et al., Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 2006, 49, 990-999.
39. Mitro, N., Mak, P. A., Vargas, L., Godio, C. The nuclear receptor LXR is a glucose sensor. Nature 2007, 445, 219-223.
40. Yap, F., Craddock, L., Yang, J., Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int. J. Biol. Sci. 2011, 7, 645-650.
41. Yang, J., Craddock, L., Hong, S., Liu, Z. M., AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J. Cell. Biochem. 2009, 106, 414-426.
42. Gruzman, A., Babai, G., Sasson, S., Adenosine monophosphate activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations. Rev. Diabet. Stud. 2009, 6, 13-36.
43. Tiainen, M., Ylikorkala, A., Makela, T. P., Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc. Natl. Acad. Sci. USA 1999, 96, 9248-9251.
44. Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K. et al., SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283, 20015-20026.
45. Rodgers, J. T., Puigserver, P., Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc. Natl. Acad. Sci. USA 2007, 104, 2861-12866.
46. Vinciguerra, M., Fulco, M., Ladurner, A., Sartorelli, V. et al., SirT1 in muscle physiology and disease: lessons from mouse models. Dis. Model Mech. 2010, 3, 298-303.